Blueprint Medicines Corporation Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals, Inc. |
$1.57 | $157.41 M | -2.5 | 51 | $0 |
AMLX
Amylyx Pharmaceuticals, Inc. |
$3.46 | $120.37 M | -1.65 | 384 | $380.79 M |
DAWN
Day One Biopharmaceuticals, Inc. |
$13.01 | $1.12 B | -5.11 | 174 | $0 |
ICPT
Intercept Pharmaceuticals, Inc. |
$19.00 | $794.69 M | -17.43 | 341 | $285.71 M |
INZY
Inozyme Pharma, Inc. |
$1.42 | $286.39 M | -3.43 | 59 | $0 |
ISEE
IVERIC bio, Inc. |
$39.95 | $5.51 B | -22.44 | 163 | $0 |
KRTX
Karuna Therapeutics, Inc. |
$329.83 | $12.60 B | -28.09 | 339 | $654,000 |
KRYS
Krystal Biotech, Inc. |
$156.30 | $4.70 B | 75.42 | 229 | $50.70 M |
MDGL
Madrigal Pharmaceuticals, Inc. |
$326.33 | $5.21 B | -10.55 | 376 | $0 |
MREO
Mereo BioPharma Group plc |
$2.93 | $479.72 M | -22.8 | 33 | $10.00 M |
PTCT
PTC Therapeutics, Inc. |
$45.22 | $2.80 B | -4.75 | 988 | $937.82 M |
TERN
Terns Pharmaceuticals, Inc. |
$4.18 | $462.44 M | -5.67 | 66 | $0 |
XFOR
X4 Pharmaceuticals, Inc. |
$0.74 | $169.62 M | -1.51 | 127 | $0 |